AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17499654
Drug: Placebo (isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (isotonic sodium chloride solution)
Trial: 11980113
Drug: Ventolin nebulizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventolin nebulizer (2.5 mg)
Trial: 11980113
Drug: Berodual (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berodual (0.25 mg ipratropium bromide and 0.5 mg phenoterol)
Trial: 11980113
Drug: Atrovent (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrovent (0.5 mg)
Trial: 11980113
Drug: Berotek (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berotek (1.0 mg by nebulizer Pulmo-Aide 56501)
Trial: 11980113
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of beta 2‐adrenomimetic with atrovent
Trial: 9531685
Drug: Sennosides (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sennosides (1 ml/kg, max 75 ml of syrup containing 2.0 mg/ml sennoside A and B)
Trial: 9531685
Drug: Lavage solution
RxNorm normalized name: Colonic Lavage Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lavage solution only
Trial: 9098257
Drug: Aminocaproic acid
RxNorm normalized name: Aminocaproic Acid
DrugBank: Aminocaproic acid (DB00513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aminocaproic acid (100 mg/kg every 4 hours; maximum 30 g daily)
Trial: 2523658
Drug: Isradipine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 5.0 mg
Trial: 2523658
Drug: Isradipine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 7.5 mg
Trial: 329946
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy for six 12-week courses
Trial: 329946
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of maintenance chemotherapy for a further six 12-week courses
Trial: 30054228
Drug: Pulsed field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed field gel electrophoresis (PFGE) analysis with XbaI
Trial: 30054228
Drug: Pulsed field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed field gel electrophoresis (PFGE) analysis with BlnI
Trial: 26188663
Drug: High methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High methadone dose (100 mg/day)
Trial: 26188663
Drug: Low methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low methadone dose (10-25 mg/day)
Trial: 21469942
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL syringe
Trial: 21469942
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL syringe
Trial: 23883424
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL syringe
Trial: 21469942
Drug: Various syringe
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various syringe sizes (1, 3, 5, 10, 20, 60 mL)
Trial: 19644851
Drug: Oral bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral bovine type I collagen
Trial: 11728835
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate at low plasma levels (0.1-0.3 ng/ml)
Trial: 11728835
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate at medium plasma levels (0.3-0.6 ng/ml)
Trial: 11728835
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate at high plasma levels (0.6-1.0 ng/ml)
Trial: 7657402
Drug: Clinically-guided self-help
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically-guided self-help (CGSH) program plus standard treatment (methadone maintenance plus individual counseling)
Trial: 7657402
Drug: Didactic lecture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didactic lecture program plus standard treatment
Trial: 30904909
Drug: Endobronchial autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endobronchial autologous blood plus thrombin patch (ABP)
Trial: 23636085
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration treatment during 17 sessions
Trial: 21612611
Drug: K‐134 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K‐134 50 mg
Trial: 21612611
Drug: K‐134 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K‐134 100 mg
Trial: 21612611
Drug: K‐134 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K‐134 25 mg
Trial: 15674004
Drug: Reiki treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reiki treatment by experienced Reiki practitioner
Trial: 15674004
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment by a person with no knowledge of Reiki
Trial: 15674004
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (rest only)
Trial: 7484044
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl 100 micrograms.h‐1
Trial: 7029297
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy regimens, 'pulse' VAC alone or VAC combined with adriamycin followed by irradiation (group III)
Trial: 31651889
Drug: High-dose HT047
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose HT047 (750 mg 3 times a day)
Trial: 31651889
Drug: Low-dose HT047
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose HT047 (500 mg 3 times a day)
Trial: 24354616
Drug: Intradermal PRP
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal PRP after FCL
Trial: 24354616
Drug: Topical PRP
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PRP after FCL
Trial: 19301380
Drug: Helicobacter pylori
RxNorm normalized name: HELICOBACTER PYLORI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helicobacter pylori eradication treatment (standard protocol)
Trial: 2063854
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific treatment (control group)
Trial: 17133405
Drug: Decitabine 100
RxNorm normalized name: cedazuridine-decitabine 100 mg-35 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decitabine 100 mg/m(2) per course every 4 weeks in 3 different schedules: 1) 20 mg/m(2) intravenously daily x 5, 2) 20 mg/m(2) subcutaneously daily x 5, and 3) 10 mg/m(2) intravenously daily x 10
Trial: 15170007
Drug: Isotretinoin, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin, 0.5 mg/kg daily for 12 weeks
Trial: 29080299
Drug: Telbivudine-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine-based therapy
Trial: 24325953
Drug: Patient‐controlled anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient‐controlled anesthesia device delivering intravenous opioids (Control)
Trial: 15876979
Drug: Dihydropyridine calcium
RxNorm normalized name: 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydropyridine calcium antagonists (nitrendipine)
Trial: 15876979
Drug: Antihypertensive regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive regimens (various classes)
Trial: 11905711
Drug: Preoperative (neoadjuvant)
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative (neoadjuvant) medical therapy
Trial: 9137021
Drug: Biojector (needleless
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biojector (needleless injection system)
Trial: 3796171
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose amoxicillin (100 mg/kg) followed by placebo every 8 hours for 10 days
Trial: 3796171
Drug: 10-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day course of amoxicillin (40 mg/kg/D)
Trial: 26582405
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid for 5 consecutive days
Trial: 20072737
Drug: Platform-switched implants
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platform-switched implants
Trial: 19865633
Drug: External-hexagon implants
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External-hexagon implants
Trial: 15733514
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic cream applied to face
Trial: 15733514
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic cream applied to back of hand
Trial: 12874415
Drug: 12-month treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month treatment with IV anti-T-lymphocyte immunoglobulin followed by oral methotrexate 7.5 mg/week (ATG group)
Trial: 12874415
Drug: 12-month treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month treatment with oral methotrexate 7.5 mg/week alone (MTX group)
Trial: 10369711
Drug: Octreotide 100
RxNorm normalized name: 1 ML octreotide 100 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 100 microg, subcutaneous injection three times daily for seven days
Trial: 10369711
Drug: Octreotide 200
RxNorm normalized name: octreotide 200 mcg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 200 microg, subcutaneous injection three times daily for seven days
Trial: 10369711
Drug: Placebo, subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, subcutaneous injection three times daily for seven days
Trial: 10369711
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (Octreotide and Placebo)
Trial: 8899313
Drug: Ukrain monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ukrain monotherapy
Trial: 8899313
Drug: 5‐fluorouracil (5‐FU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐fluorouracil (5‐FU) and X‐ray therapy
Trial: 6407749
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) for 4 malnourished children for 28 days
Trial: 6407749
Drug: Peripheral parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral parenteral nutrition plus enteral nutrition for 4 malnourished children for 28 days
Trial: 6407749
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) for 2 nourished children
Trial: 6407749
Drug: Nourished or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nourished or becoming renourished during the first 21 days of therapy
Trial: 6407749
Drug: Becoming malnourished
RxNorm normalized name: Lantiseptic Nourishing Skin
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Becoming malnourished or remaining malnourished during the first 21 days of therapy
Trial: 30914102
Drug: Sodium acetate
RxNorm normalized name: Sodium Acetate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium acetate Ringer solution infusion (group A: 4 mL·kg‐1·h‐1, group B: increased by 50%, group C: increased by 100%) for 30 minutes
Trial: 30914102
Drug: Sodium acetate
RxNorm normalized name: Sodium Acetate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium acetate Ringer solution infusion (group B)
Trial: 30914102
Drug: Sodium acetate
RxNorm normalized name: Sodium Acetate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium acetate Ringer solution infusion (group A)
Trial: 28012569
Drug: Methylprednisolone acetate
RxNorm normalized name: methylprednisolone acetate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone acetate (MPA) 80 mg, 2 mL
Trial: 28012569
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TA) 80 mg, 2 mL
Trial: 19384218
Drug: N-acetylcysteine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (100 mg/kg bolus; 20 mg.kg.hr infusion until 4 hours after cardiopulmonary bypass)
Trial: 15121491
Drug: Spironolactone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (mean dose 32 +/- 16 mg)
Trial: 30638544
Drug: Liothyronine (T3)
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liothyronine (T3) therapy (maximum dosage 15 mcg/m2/die)
Trial: 30638544
Drug: Liothyronine (T3)
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liothyronine (T3) therapy (T3-treated group)
Trial: 25198275
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion for less than 12 hours
Trial: 25198275
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion for 12-18 hours
Trial: 25198275
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion for greater than 18 hours
Trial: 25198275
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion (all durations)
Trial: 17317371
Drug: rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 40 mg (in subjects with low HDL cholesterol)
Trial: 17317371
Drug: atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 80 mg (in subjects with low HDL cholesterol)
Trial: 15063607
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/fenofibrate
Trial: 2133472
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by a dentist
Trial: 2133472
Drug: Craniomandibular disorder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Craniomandibular disorder treatment group
Trial: 2133472
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by a neurologist
Trial: 28384065
Drug: Bevacizumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (15 mg/kg every 21 days)
Trial: 25554623
Drug: D-serine (DSR)
RxNorm normalized name: D-Serine
DrugBank: D-Serine (DB03929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-serine (DSR) 2.1 g orally administered
Trial: 24283280
Drug: Dentifrice quantity
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dentifrice quantity (0.5 g vs 1.5 g)
Trial: 17143175
Drug: Ramipril (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (1 mg/kg per day)
Trial: 15108979
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion at 4 kJ x kg(‐1) x h(‐1) for 2.5 h combined with skin‐surface warming
Trial: 15108979
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion combined with cutaneous cooling
Trial: 15108979
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion combined with skin‐surface warming
Trial: 15108979
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion combined with cutaneous cooling
Trial: 8031555
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg, 20 mg)
Trial: 8031555
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg, 8 mg)
Trial: 2029111
Drug: Methotrexate (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (7.5 mg weekly, increased to 15 mg after 8 weeks if clinically effective)
Trial: 2029111
Drug: Azathioprine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (100 mg daily, increased to 150 mg after 8 weeks if clinically effective)
Trial: 318908
Drug: Butorphanol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 0.5 mg
Trial: 318908
Drug: Butorphanol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 1.0 mg
Trial: 318908
Drug: Meperidine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 20 mg
Trial: 318908
Drug: Butorphanol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 0.5 mg and 1.0 mg
Trial: 28553076
Drug: 2.5 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 μg/kg palonosetron
Trial: 28553076
Drug: 7.5 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 μg/kg palonosetron
Trial: 28553076
Drug: 2.5 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 μg/kg palonosetron and 15 μg/kg droperidol
Trial: 25651245
Drug: Oral tenofovir-emtricitabine
RxNorm normalized name: emtricitabine / tenofovir disoproxil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tenofovir-emtricitabine (TDF-FTC)
Trial: 25651245
Drug: 1% tenofovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% tenofovir (TFV) vaginal gel
Trial: 25651245
Drug: Oral TDF-FTC
RxNorm normalized name: (-)-FTC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TDF-FTC
Trial: 10028980
Drug: Home-based mass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based mass antibiotic treatment (azithromycin, ciprofloxacin, metronidazole)
Trial: 10028980
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (vitamins/anthelmintic drug)
Trial: 8897864
Drug: L-glutamine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-glutamine (800 mumol.kg-1.h-1)
Trial: 8897864
Drug: Glycine (isonitrogenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine (isonitrogenous infusion)
Trial: 1324895
Drug: RT and
RxNorm normalized name: Comfort and Ease KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT and daily low dose of cDDP (6 mg/m2)
Trial: 6828981
Drug: Intravenous erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous erythromycin gluceptate
Trial: 6828981
Drug: Intravenous metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous metronidazole with tobramycin
Trial: 28799984
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (60 mg, Xylocaine 10% pump spray)
Trial: 28799984
Drug: Placebo spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo spray (chlorhexidine gluconate 0.5% in 70% alcohol base)
Trial: 20471117
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rosuvastatin loading before PCI
Trial: 18706705
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment before PCI (Control group)
Trial: 16564621
Drug: Lidocaine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1.5 ml, 20mg/ml lidocaine and 12.5 microg/ml adrenaline)
Trial: 16564621
Drug: Saline (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (1.5 ml, 9 mg/ml NaCl solution) (placebo)
Trial: 6537916
Drug: Empiric antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric antibiotic treatment for fever
Trial: 30105362
Drug: Fludrocortisone (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (0.1 to 0.4 mg per day)
Trial: 27438627
Drug: ONS solution
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONS solution 2 hours before surgery
Trial: 25440377
Drug: 15g/day of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15g/day of E. angustifolia L. medulla for 8 weeks
Trial: 25440377
Drug: 15g/day of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15g/day of E. angustifolia L. whole fruit for 8 weeks
Trial: 18056193
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 i.v. infusion over 1 hour)